Gallbladder cancer screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (48 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gallbladder cancer}} | {{Gallbladder cancer}} | ||
{{CMG}}{{AE}}{{ | {{CMG}}; {{AE}}{{VKG}} | ||
==Overview== | ==Overview== | ||
According to the National Comprehensive Cancer Network (NCCN) guidelines, [[gallbladder cancer]] may be diagnosed as an incidental finding in patients who undergo [[laparoscopic]] [[cholecystectomy]]. | |||
==Screening== | ==Screening== | ||
* According to the NCCN guidelines, [[screening]] for [[gallbladder cancer]] patients include followings: | |||
**[[Endoscopic ultrasound|Endoscopic]] ultrasonography (EUS) | |||
**[[Computed tomography]] ([[Computed tomography|CT]]) | |||
**[[Magnetic resonance imaging]] ([[MRI]]) with/without contrast | |||
*Patients after incidental finding during [[laparoscopic]] [[cholecystectomy]] patient are recommends considering staging [[laparoscopy]].<sup> </sup> | |||
* When [[gallbladder]] pathology is suspected [[ultrasonography]] is most commonly the first choice for [[Screening (medicine)|screening]]. | |||
* [[Sensitivity]] and [[specificity]] of [[ultrasound]] screening is 85% and 80%. | |||
* High-resolution contrast-enhanced [[ultrasonography]] identifies up to 70–90% of [[Polypoidy|polypoid]] [[gallbladder]] lesions.<ref name="pmid21628925">{{cite journal |vauthors=Inui K, Yoshino J, Miyoshi H |title=Diagnosis of gallbladder tumors |journal=Intern. Med. |volume=50 |issue=11 |pages=1133–6 |year=2011 |pmid=21628925 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
| Line 16: | Line 24: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 14:09, 9 January 2019
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer screening On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer screening |
|
Risk calculators and risk factors for Gallbladder cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
According to the National Comprehensive Cancer Network (NCCN) guidelines, gallbladder cancer may be diagnosed as an incidental finding in patients who undergo laparoscopic cholecystectomy.
Screening
- According to the NCCN guidelines, screening for gallbladder cancer patients include followings:
- Endoscopic ultrasonography (EUS)
- Computed tomography (CT)
- Magnetic resonance imaging (MRI) with/without contrast
- Patients after incidental finding during laparoscopic cholecystectomy patient are recommends considering staging laparoscopy.
- When gallbladder pathology is suspected ultrasonography is most commonly the first choice for screening.
- Sensitivity and specificity of ultrasound screening is 85% and 80%.
- High-resolution contrast-enhanced ultrasonography identifies up to 70–90% of polypoid gallbladder lesions.[1]